| Date Filed | Type | Description |
| 01/28/2011 |
4
| Barlow David S (10% Owner) has filed a Form 4 on Molecular Insight Pharmaceuticals, Inc. |
| 12/20/2010 |
4
| Barlow David S (10% Owner) has filed a Form 4 on Molecular Insight Pharmaceuticals, Inc. |
| 12/17/2010 |
3
| Attarian Mark A (Interim EVP & CFO) has filed a Form 3 on Molecular Insight Pharmaceuticals, Inc. |
| 07/01/2010 |
3
| Taconic Capital Advisors LP (Reference Footnote 1) has filed a Form 3 on Molecular Insight Pharmaceuticals, Inc. |
| 06/30/2010 |
3
| Pioneer Floating Rate Trust (Reference footnote 1.) has filed a Form 3 on Molecular Insight Pharmaceuticals, Inc. |
| 06/30/2010 |
3
| Pioneer Floating Rate Trust (Reference footnote 1.) has filed a Form 3 on Molecular Insight Pharmaceuticals, Inc. |
| 06/30/2010 |
3
| McDonnell Loan Opportunity Ltd. (See Remarks) has filed a Form 3 on Molecular Insight Pharmaceuticals, Inc. |
| 06/30/2010 |
3/A
| QVT Associates GP LLC (reference remarks (2) below) has filed a Form 3/A on Molecular Insight Pharmaceuticals, Inc. |
| 06/30/2010 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
| 05/17/2010 |
4
| Stylli Harry (Director) has filed a Form 4 on Molecular Insight Pharmaceuticals, Inc. |
| 05/17/2010 |
4
| STERLING LIONEL N (Director) has filed a Form 4 on Molecular Insight Pharmaceuticals, Inc. |
| 05/17/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/17/2010 |
4
| LIMBER JOSEPH M (Director) has filed a Form 4 on Molecular Insight Pharmaceuticals, Inc.|
Txns:
| Granted 25,000 options to buy
@ $1.85, valued at
$46.3k
|
|
| 05/17/2010 |
4
| Gottlieb Scott (Director) has filed a Form 4 on Molecular Insight Pharmaceuticals, Inc. |
| 05/17/2010 |
4
| FRANK DANIEL (Director) has filed a Form 4 on Molecular Insight Pharmaceuticals, Inc. |
| 01/21/2010 |
4
| Barlow David S (10% Owner) has filed a Form 4 on Molecular Insight Pharmaceuticals, Inc. |
| 01/06/2010 |
4/A
| Barlow David S (10% Owner) has filed a Form 4 on Molecular Insight Pharmaceuticals, Inc. |
| 01/06/2010 |
4/A
| Barlow David S (10% Owner) has filed a Form 4 on Molecular Insight Pharmaceuticals, Inc. |
| 12/28/2009 |
4
| Barlow David S (10% Owner) has filed a Form 4 on Molecular Insight Pharmaceuticals, Inc. |
| 12/28/2009 |
4
| Barlow David S (10% Owner) has filed a Form 4 on Molecular Insight Pharmaceuticals, Inc. |
| 11/18/2009 |
4
| Abdalian Charles H Jr (VP of Finance and CFO) has filed a Form 4 on Molecular Insight Pharmaceuticals, Inc. |
| 08/13/2009 |
4
| PETERS DANIEL (President and CEO) has filed a Form 4 on Molecular Insight Pharmaceuticals, Inc. |
| 08/12/2009 |
4
| Babich John W (Exec. VP, CSO and Pres. of R&D) has filed a Form 4 on Molecular Insight Pharmaceuticals, Inc. |
| 08/12/2009 |
4
| Form 4 -- Statement of changes in beneficial ownership of securities |
| 08/12/2009 |
3
| Abdalian Charles H Jr (VP of Finance & CFO) has filed a Form 3 on Molecular Insight Pharmaceuticals, Inc. |
| 06/05/2009 |
3
| PETERS DANIEL (President and CEO) has filed a Form 3 on Molecular Insight Pharmaceuticals, Inc. |
| 06/01/2009 |
4
| Gottlieb Scott (Director) has filed a Form 4 on Molecular Insight Pharmaceuticals, Inc. |
| 05/29/2009 |
4
| LaFrance Norman D. (Sr. VP Clinical Dev and CMO) has filed a Form 4 on Molecular Insight Pharmaceuticals, Inc. |
| 05/26/2009 |
4
| Wallroth Donald E. (CFO) has filed a Form 4 on Molecular Insight Pharmaceuticals, Inc. |
| 05/14/2009 |
4/A
| Kronauge James F (VP Process Chemistry) has filed a Form 4 on Molecular Insight Pharmaceuticals, Inc. |
| 05/14/2009 |
4/A
| Wachholz James (VP & Chief Regulatory Officer) has filed a Form 4 on Molecular Insight Pharmaceuticals, Inc. |
| 05/14/2009 |
4/A
| Barrett John A (V.P. of Preclinical Dev.) has filed a Form 4 on Molecular Insight Pharmaceuticals, Inc. |
| 05/14/2009 |
4/A
| Wallroth Donald E. (CFO) has filed a Form 4 on Molecular Insight Pharmaceuticals, Inc. |
| 05/14/2009 |
4/A
| LaFrance Norman D. (Sr. VP Clinical Dev and CMO) has filed a Form 4 on Molecular Insight Pharmaceuticals, Inc. |
|